Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Kewin, T. Inkster, B. Choo-Kang (Glasgow, United Kingdom). Indeterminate IGRA results in routine practice. Eur Respir J 2011; 38: Suppl. 55, 304

Member's Comments

No comment yet.

Related content which might interest you: Indeterminate results of quantiFERON TB-2G test performed in routine clinical practice Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice Source: Eur Respir J 2009; 33: 812-815 Year: 2009 Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017 Year: 2017 Clinical history and IGRA is unreliable in the diagnosis of tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Concordance between IGRA and TST in a cohort of health professional trainees from India Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 The changing indications for IGRA testing and impact on TB services in a UK district general hospital Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Prevalence of LTBI using IGRA and TST in a cohort of health professional trainees from India Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Results of IGRA tests in a prison from a high-TB burden country Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012 A retrospective review of the Xpert® MTB/RIF assay performance in bronchoalveolar lavage samples in a London hospital Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Improved diagnostic evaluation of suspected tuberculosis in routine practice Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Evaluation of IP-10 in IGRA for LTBI diagnosis Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test Source: Eur Respir J 2001; 18: Suppl. 33, 360s Year: 2001 Clinical utility of the Xpert MTB/RIF test in induced sputum Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Low real-world utility of IGRA when screening for LTBI in a low incidence setting Source: International Congress 2015 – Screening strategies in TB Year: 2015 Tuberculin skin test and IGRA test in the diagnosis and follow-up of bacteriologically confirmed pulmonary tuberculosis in HIV negative adults Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012